Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT02932735
Other study ID # 2016SDU-QILU-18
Secondary ID
Status Not yet recruiting
Phase N/A
First received October 10, 2016
Last updated October 12, 2016
Start date October 2016
Est. completion date June 2017

Study information

Verified date October 2016
Source Shandong University
Contact Li Yanqing, MD, PhD
Phone 86-531-82169236
Email liyanqing@sdu.edu.cn
Is FDA regulated No
Health authority China: National Health and Family Planning Commission
Study type Observational

Clinical Trial Summary

Gastric intestinal metaplasia (GIM) is an important premalignant lesion for gastric cancer. Precisely surveillance of patients with GIM may result in early detection and improved prognosis. Though important, it is not necessary to recommend surveillance endoscopy for all patients with GIM, since the progression rate to gastric cancer within 10 years is only 1.8% in those patients.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 30
Est. completion date June 2017
Est. primary completion date June 2017
Accepts healthy volunteers No
Gender Both
Age group 40 Years and older
Eligibility Inclusion Criteria:

- Patients aged 40 years or older with Helicobacter pylori infection;

- Histologically verified GIM, atrophic gastritis or dysplasia.

Exclusion Criteria:

- Patients with gastrectomy, acute GI bleeding and advanced gastric cancer;

- Conditions unsuitable for performance of pCLE, such as coagulopathy, impaired renal function or allergy to fluorescein sodium;

- Pregnancy or breastfeeding;

- Inability to provide informed consent and other situations that could interfere with the examination or therapeutic protocol.

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms

  • Metaplasia
  • Probe-based Confocal Laser Endomicroscopy
  • the Operative Link on Gastric Intestinal Metaplasia

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Shandong University

Outcome

Type Measure Description Time frame Safety issue
Primary the sensitivity of probe-based Confocal Laser Endomicroscopy (pCLE) in staging the Operative Link on Gastric Intestinal Metaplasia (OLGIM). 6 months No
Primary the of specificity of probe-based Confocal Laser Endomicroscopy (pCLE) in staging the Operative Link on Gastric Intestinal Metaplasia (OLGIM). 6 months No
Secondary the of sensitivity of probe-based Confocal Laser Endomicroscopy (pCLE) in staging Gastric Intestinal Metaplasia (GIM). 6 months No
Secondary the of specificity of probe-based Confocal Laser Endomicroscopy (pCLE) in staging Gastric Intestinal Metaplasia (GIM). 6 months No
See also
  Status Clinical Trial Phase
Recruiting NCT03787784 - Automatic Classification of Colorectal Polyps Using Probe-based Endomicroscopy With Artificial Intelligence N/A
Recruiting NCT04139889 - Diagnosis of Laryngeal Lesions Using the Probe-based Confocal Laser Endomicroscopy